This inventor holds 1 USPTO granted patent. Top assignee: Cetus Corporation. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Pamela Hirtzer
Introduction
Pamela Hirtzer is a notable inventor based in Oakland, CA, who has made significant contributions to the field of pharmaceuticals. She is recognized for her innovative work in developing stable pharmaceutical compositions that utilize recombinant interleukin-2. Her research has the potential to impact therapeutic treatments for both animals and humans.
Latest Patents
Hirtzer holds a patent for "Pharmaceutical compositions of recombinant interleukin-2 and formulation." This patent describes stable pharmaceutical compositions suitable for parenteral administration, which include a therapeutically effective amount of recombinant interleukin-2 protein dissolved in an inert carrier medium. The formulations utilize biocompatible non-ionic polymeric detergents that act as solubilizers and stabilizers, enhancing the effectiveness of the compositions.
Career Highlights
Pamela Hirtzer has had a distinguished career, working at Cetus Corporation, where she has been able to apply her expertise in pharmaceutical sciences. Her work has contributed to advancements in drug formulation and delivery systems, showcasing her commitment to improving healthcare solutions.
Collaborations
Throughout her career, Hirtzer has collaborated with esteemed colleagues, including Ze'ev Shaked and Tracy Stewart. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Pamela Hirtzer's contributions to pharmaceutical innovations, particularly in the area of recombinant interleukin-2 formulations, highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile